CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement
- PMID: 27417916
- PMCID: VSports注册入口 - PMC5155648
- DOI: 10.1111/irv.12411
"V体育2025版" CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES-I statement): an extension of the STROBE statement
"VSports" Abstract
Background: Population-based serologic studies are a vital tool for understanding the epidemiology of influenza and other respiratory viruses, including the early assessment of the transmissibility and severity of the 2009 influenza pandemic, and Middle East respiratory syndrome coronavirus. However, interpretation of the results of serologic studies has been hampered by the diversity of approaches and the lack of standardized methods and reporting. VSports手机版.
Objective: The objective of the CONSISE ROSES-I statement was to improve the quality and transparency of reporting of influenza seroepidemiologic studies and facilitate the assessment of the validity and generalizability of published results. V体育安卓版.
Methods: The ROSES-I statement was developed as an expert consensus of the CONSISE epidemiology and laboratory working groups. The recommendations are presented in the familiar format of a reporting guideline V体育ios版. Because seroepidemiologic studies are a specific type of observational epidemiology study, the ROSES-I statement is built upon the STROBE guidelines. As such, the ROSES-I statement should be seen as an extension of the STROBE guidelines. .
Results: The ROSES-I statement presents 42 items that can be used as a checklist of the information that should be included in the results of published seroepidemiologic studies, and which can also serve as a guide to the items that need to be considered during study design and implementation VSports最新版本. .
Conclusions: We hope that the ROSES-I statement will contribute to improving the quality of reporting of seroepidemiologic studies V体育平台登录. .
© 2016 The Authors VSports注册入口. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd. .
References
-
- Wong JY, Kelly H, Ip DK, Wu JT, Leung GM, Cowling BJ. Case fatality risk of influenza A (H1N1pdm09): a systematic review. Epidemiology 2013;24:830–841. - VSports在线直播 - PMC - PubMed
-
- Reed C, Katz JM. Serological surveys for 2009 pandemic influenza A H1N1. Lancet 2010;375:1062–1063. - "VSports手机版" PubMed
-
- Wu JT, Ho A, Ma ES, et al. Estimating infection attack rates and severity in real time during an influenza pandemic: analysis of serial cross‐sectional serologic surveillance data. PLoS Med. 2011;8:e1001103. - PMC (VSports手机版) - PubMed
-
- Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA. 2009;302:1872–1879. - PubMed
"V体育平台登录" Publication types
- Actions (V体育2025版)
- "VSports最新版本" Actions
MeSH terms
- "V体育安卓版" Actions
- "V体育官网入口" Actions
- V体育安卓版 - Actions
- Actions (VSports手机版)
- V体育官网 - Actions
Grants and funding
LinkOut - more resources (VSports)
Full Text Sources
"V体育官网" Other Literature Sources
Medical (V体育安卓版)
Research Materials